InfuSystem Holdings, Inc. vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 6 of 9 compared factors.
Size & Scale
| INFU | RMD | |
|---|---|---|
| Market Cap | $248.77 million | $32.38 billion |
| Revenue (TTM) | $143.34 million | $5.54 billion |
| Net Income (TTM) | $8.54 million | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| INFU | RMD | |
|---|---|---|
| P/E Ratio | 31.22 | 21.53 |
| Price / Book | 4.21 | 4.99 |
| Price / Sales | 1.74 | 5.85 |
INFU leads on 2 of 3 valuation factors.
Profitability
| INFU | RMD | |
|---|---|---|
| Net Margin | 5.96% | 27.44% |
| Return on Equity | 14.44% | 23.41% |
RMD leads on 2 of 2 profitability factors.
Dividend
| INFU | RMD | |
|---|---|---|
| Dividend Yield | — | 1.18% |
| Payout Ratio | — | 25.46 |
INFU and RMD split the dividend factors evenly.
Risk & Sentiment
| INFU | RMD | |
|---|---|---|
| Short Interest | 0.02% | 4.02% |
INFU leads on 1 of 1 risk & sentiment factors.
Dig deeper: INFU overview, INFU financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.